Director/PDMR Shareholding
04/05/2018 14:13
2018-05-04T13:13:27.104Zreuters.comtag:reuters.com,2018-05-04:newsml_RSD2106Na:13TXT
This file is provided for EAP sample purposes only; it's structure and detail are subject to change, and should not be used as a definitive reference for actual development and processing.2018-05-04T13:13:27.104Z2018-05-04T13:13:27.104Z____UCDP:parsn_lse_10.54.4.69_1.2.37235:REG - Indivior PLC - Director/PDMR Shareholding2019-06-04T13:13:27.104Z3RSD2106NaREG - Indivior PLC - Director/PDMR ShareholdingHealthcare (TRBC level 1)Pharmaceuticals & Medical Research (TRBC level 2)LEGACY: Pharmaceuticals (TRBC level 3)LEGACY: Generic & Specialty Pharmaceuticals (TRBC)Proprietary & Advanced Pharmaceuticals (TRBC level 5)Pharmaceuticals (TRBC level 4)Western EuropeUnited KingdomEuropeSuggested SourcesNews AnnouncementsRegulatory Corporate News AnnouncementsCompany NewsEurope daily earnings hits & missesIndivior PLC
RNS Number : 2106N
Indivior PLC
04 May 2018
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM
The Company announces that on 2 May 2018 Richard Simkin, a PDMR, acquired 641,732 Ordinary Shares of US$0.10 in the Company following the exercise of an option at a price of £1.11 per share, pursuant to the Rules of the Indivior Long-Term Incentive Plan. All shares were subsequently sold at the price of £4.525325 per share. The sale was due to personal circumstances associated with Mr Simkin's divorce settlement.
Richard Simkin retains an interest in 542,453 shares in the Company.
This notification is made in accordance with the requirements of the EU Market Abuse Regulation.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||||
| a) | Name | Richard Simkin | |||||
| 2 | Reason for the notification | ||||||
| a) | Position/status | PDMR - Chief Commercial and Strategy Officer | |||||
| b) | Initial notification /Amendment | Initial notification | |||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
| a) | Name | Indivior PLC | |||||
| b) | LEI | 213800V3NCQTY7IED471 | |||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of US$0.10 ISIN: GB00BRS65X63 | |||||
| b) | Nature of the transaction | Exercise of an option pursuant to the Rules of the Indivior Long-Term Incentive Plan | |||||
| c) | Price(s) and volume(s) |
| |||||
| d) | Aggregated information - Aggregated volume - Price | 641,732 £712,322.52 (Total Exercise Price) | |||||
| e) | Date of the transaction | 2 May 2018 | |||||
| f) | Place of the transaction | Outside a trading venue | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of US$0.10 ISIN: GB00BRS65X63 | |||||
| b) | Nature of the transaction | Sale of Ordinary Shares | |||||
| c) | Price(s) and volume(s) |
| |||||
| d) | Aggregated information - Aggregated volume - Price | 641,732 £2,904,045.86 | |||||
| e) | Date of the transaction | 2 May 2018 | |||||
| f) | Place of the transaction | London Stock Exchange |